These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32653668)

  • 21. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.
    Finlay AK; Morse E; Stimmel M; Taylor E; Timko C; Harris AHS; Smelson D; Yu M; Blue-Howells J; Binswanger IA
    J Gen Intern Med; 2020 Sep; 35(9):2529-2536. PubMed ID: 32583337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.
    Bahji A; Carlone D; Altomare J
    Addiction; 2020 Aug; 115(8):1413-1425. PubMed ID: 31863669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in factors predicting post-treatment opioid use.
    Davis JP; Eddie D; Prindle J; Dworkin ER; Christie NC; Saba S; DiGuiseppi GT; Clapp JD; Kelly JF
    Addiction; 2021 Aug; 116(8):2116-2126. PubMed ID: 33405314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment at the front end of the criminal justice continuum: the association between arrest and admission into specialty substance abuse treatment.
    Kubiak SP; Arfken CL; Swartz JA; Koch AL
    Subst Abuse Treat Prev Policy; 2006 Jul; 1():20. PubMed ID: 16879743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.
    Winetsky D; Fox A; Nijhawan A; Rich JD
    Infect Dis Clin North Am; 2020 Sep; 34(3):585-603. PubMed ID: 32782103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
    Krawczyk N; Picher CE; Feder KA; Saloner B
    Health Aff (Millwood); 2017 Dec; 36(12):2046-2053. PubMed ID: 29200340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.
    Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J
    Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.
    Evans EA; Zhu Y; Yoo C; Huang D; Hser YI
    Addiction; 2019 Aug; 114(8):1396-1404. PubMed ID: 30916463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated costs to the Pennsylvania criminal justice system resulting from the opioid crisis.
    Zajac G; Nur SA; Kreager DA; Sterner G
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S250-S255. PubMed ID: 31361427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management?
    Hamilton J; Ti L; Korchinski M; Nolan S
    J Addict Med; 2022 Mar-Apr 01; 16(2):132-134. PubMed ID: 35289772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criminal Justice or Public Health: A Comparison of the Representation of the Crack Cocaine and Opioid Epidemics in the Media.
    Shachar C; Wise T; Katznelson G; Campbell AL
    J Health Polit Policy Law; 2020 Apr; 45(2):211-239. PubMed ID: 31808806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stakeholder Perspectives on Implementing a Police-Mental Health Collaborative to Improve Pathways to Treatment.
    Abella AD; Landers M; Ismajli F; Carmona Y
    J Behav Health Serv Res; 2022 Jul; 49(3):299-314. PubMed ID: 35000102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Opioid Crisis and Federal Criminal Prosecution.
    Rothberg RL; Stith K
    J Law Med Ethics; 2018 Jun; 46(2):292-313. PubMed ID: 30147006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allocation of federal funding to address the opioid overdose crisis in the criminal legal system.
    Harris SJ; Abraham AJ; Lozano-Rojas F; Negaro S; Andrews CM; Grogan CM
    J Subst Use Addict Treat; 2023 Jul; 150():209064. PubMed ID: 37156423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psycho-Social Correlates of Opioid Use Disorder among the US Adult Population: Evidence from the National Survey on Drug Use and Health, 2015-2018.
    Haider MR; Brown MJ; Gupta RD; Karim S; Olatosi B; Li X
    Subst Use Misuse; 2020; 55(12):2002-2010. PubMed ID: 32633664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
    Ducharme LJ; Wiley TRA; Mulford CF; Su ZI; Zur JB
    J Subst Abuse Treat; 2021 Sep; 128():108307. PubMed ID: 33531212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
    Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
    Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources.
    Manchikanti L
    Pain Physician; 2006 Oct; 9(4):287-321. PubMed ID: 17066115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention.
    Wagner KD; Liu L; Davidson PJ; Cuevas-Mota J; Armenta RF; Garfein RS
    Drug Alcohol Depend; 2015 Aug; 153():215-20. PubMed ID: 26091751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.
    Taweh N; Schlossberg E; Frank C; Nijhawan A; Kuo I; Knight K; Springer SA
    Int J Drug Policy; 2021 Oct; 96():103283. PubMed ID: 34020864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.